ACAD
36.56
+0.89
+2.50%
AEMD
0.196
-0.01
-4.6341%
APRI
1.67
+0.07
+4.37%
ARNA
4.31
-0.03
-0.69%
ATEC
1.34
-0.08
-5.63%
CNAT
6.1
+0.17
+2.87%
CRXM
0.495
0.00
0.00%
CYTX
0.9
+0.03
+4.02%
DXCM
68.19
+1.07
+1.59%
GNMK
10.19
+0.08
+0.79%
HALO
15.69
-0.1
-0.63%
ILMN
189.65
-1.58
-0.83%
INNV
0.153
0.00
0.00%
INO
8.46
+0.04
+0.48%
ISCO
0.06
+0.001
+2.0583%
ISIS
59.66
+1.42
+2.44%
LGND
79.85
+0.05
+0.06%
LPTN
2
-0.06
-2.91%
MBVX
2.88
+0.08
+2.86%
MEIP
2.13
+0.14
+7.04%
MNOV
3.94
+0.12
+3.14%
MRTX
28.28
+1.27
+4.70%
MSTX
0.528
+0.007
+1.3838%
NBIX
36.08
+0.57
+1.61%
NUVA
45.66
+1.01
+2.26%
ONCS
0.265
-0.005
-1.852%
ONVO
4.8
+0.03
+0.63%
OREX
6.72
+0.05
+0.75%
OTIC
29.31
+1.4
+5.02%
QDEL
23.08
-0.1
-0.43%
RCPT
153.45
-2.95
-1.89%
RGLS
13.45
-0.02
-0.15%
RMD
65.65
+0.87
+1.34%
SCIE
0.022
0.00
0.00%
SPHS
0.75
+0.05
+7.77%
SRNE
10.72
+0.37
+3.57%
TROV
8.9
+0.39
+4.58%
VICL
0.92
0.00
0.00%
VOLC
17.99
0.00
0.00%
ZGNX
1.48
+0.05
+3.50%
ACAD
36.56
+0.89
+2.50%
AEMD
0.196
-0.01
-4.6341%
APRI
1.67
+0.07
+4.37%
ARNA
4.31
-0.03
-0.69%
ATEC
1.34
-0.08
-5.63%
CNAT
6.1
+0.17
+2.87%
CRXM
0.495
0.00
0.00%
CYTX
0.9
+0.03
+4.02%
DXCM
68.19
+1.07
+1.59%
GNMK
10.19
+0.08
+0.79%
HALO
15.69
-0.1
-0.63%
ILMN
189.65
-1.58
-0.83%
INNV
0.153
0.00
0.00%
INO
8.46
+0.04
+0.48%
ISCO
0.06
+0.001
+2.0583%
ISIS
59.66
+1.42
+2.44%
LGND
79.85
+0.05
+0.06%
LPTN
2
-0.06
-2.91%
MBVX
2.88
+0.08
+2.86%
MEIP
2.13
+0.14
+7.04%
MNOV
3.94
+0.12
+3.14%
MRTX
28.28
+1.27
+4.70%
MSTX
0.528
+0.007
+1.3838%
NBIX
36.08
+0.57
+1.61%
NUVA
45.66
+1.01
+2.26%
ONCS
0.265
-0.005
-1.852%
ONVO
4.8
+0.03
+0.63%
OREX
6.72
+0.05
+0.75%
OTIC
29.31
+1.4
+5.02%
QDEL
23.08
-0.1
-0.43%
RCPT
153.45
-2.95
-1.89%
RGLS
13.45
-0.02
-0.15%
RMD
65.65
+0.87
+1.34%
SCIE
0.022
0.00
0.00%
SPHS
0.75
+0.05
+7.77%
SRNE
10.72
+0.37
+3.57%
TROV
8.9
+0.39
+4.58%
VICL
0.92
0.00
0.00%
VOLC
17.99
0.00
0.00%
ZGNX
1.48
+0.05
+3.50%
Home » Archive by Category

Drug Discovery

San Diego’s Antibody-Drug Conjugate Research Highlighted at #WorldADC Meeting in October

November 24, 2014 – 8:11 am
WorldADC

San Diego was host to the World Antibody Drug Conjugate (ADC) Meeting and Awards October 26-29th 2014. ADCs are an exciting new class of oncology therapeutics utilizing monoclonal antibodies conjugated to cytotoxic drugs, resulting in …

SDBN August 21st 2012 Event At The Sanford Consortium For Regenerative Medicine

August 3, 2012 – 12:41 pm

The Sanford Consortium for Regenerative Medicine is a stem cell research facility representing a collaboration between five of San Diego’s finest research institutions: Sanford-Burnham Medical Research Institute, The Salk Institute, The Scripps Research Institute and …

SDBN June 25th Event With Lilly: Open Innovation Drug Discovery

June 4, 2012 – 1:48 am

San Diego biotech has grown thanks to a collaborative spirit which is sometimes manifested in the acquisition and joining of companies towards a common goal. Lilly’s presence here is indicative of this type of growth, …

San Diego’s Biotechnology Companies: Who’s Taking Off?

March 8, 2012 – 9:13 am

Here at SDBN we’ve been updating our directory of 400+ San Diego biotech companies.  We were surprised to find close to 40 companies removed from the local scene – due to acquisition or shut down.  …

SDBN March 26th 2012 Event with Organovo

March 6, 2012 – 1:59 pm

Organovo is an exciting San Diego biotech company with technology to create human tissue through a technique called 3D bioprinting. The tissue can be used for drug discovery and development, and the company has been …

Focus on San Diego: Life Science Conferences Spring 2012

January 31, 2012 – 11:56 am

This spring San Diego downtown will be buzzing with scientific discussions as our city hosts a number of major scientific symposia.  We are excited to attend and soak in all the science that will be …

Virtual Biotech Part 1: What We Learned About Effectively Outsourcing a Drug Discovery Program

July 28, 2011 – 12:04 pm

The first in our Virtual Biotech series, our July 19th event was a success.  Thanks to our participants – some of San Diego’s leading virtual drug discovery scientists and CROs – for sharing their valuable …

SDBN July 19th Event: Virtual Biotech Part 1: How to Effectively Outsource a Drug Discovery Program

July 1, 2011 – 3:47 pm

Changes in the drug discovery landscape have presented many tough challenges for our region, including downsizing for larger companies and a dearth of VC funding for startups. With these challenges come opportunities, however, because drug …

SDBN June 21st Event Featuring aTyr Pharma

May 27, 2011 – 9:58 am

The San Diego Biotechnology Network’s June 21st event will feature aTyr Pharma, with Board Member and CEO Jeffry Watkins (Bio) giving a talk titled “Innovation: Where is our Biology?” aTyr is developing therapeutics based on …

SDBN April 19th 2011 Event Featuring Celgene

March 22, 2011 – 6:15 pm

Through research, acquisitions, and mergers, Celgene has built a robust product portfolio and pipeline in hematology and oncology. This accomplishment is quite a feat in today’s environment, with pharma pipelines dwindling, and they are one …